Altimmune
ALT
ALT
128 hedge funds and large institutions have $1.03B invested in Altimmune in 2022 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 38 increasing their positions, 35 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
9% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 35
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
7.09% less ownership
Funds ownership: 102.32% → 95.24% (-7.1%)
Holders
128
Holding in Top 10
4
Calls
$60M
Puts
$7.33M
Top Buyers
| 1 | +$264M | |
| 2 | +$41.4M | |
| 3 | +$21.5M | |
| 4 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$17.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$16.9M |
Top Sellers
| 1 | -$72.5M | |
| 2 | -$18.4M | |
| 3 | -$15.6M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$14.1M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$13.9M |